GenSure Biotech Inc.H2.H34Founded in Shanghai in 2014, GenSure Biotech Inc. is a leading high-tech company dedicated to the research, development, production, and global distribution of in vitro diagnostic (IVD) reagents and testing instruments. With a strong focus on innovation, GenSure provides a comprehensive portfolio of high-quality, cost-effective rapid diagnostic solutions designed to meet the needs of healthcare providers, laboratories, and public health institutions worldwide.
Our key product lines include:
Rapid immunochromatographic test kits (colloidal gold and latex methods) for infectious diseases, including respiratory pathogens, gastrointestinal infections, STIs, tropical vector-borne diseases and bacterial vaginitis, fertility hormones.
Fluorescence immunoassay (FIA) systems and reagents for quantitative testing in clinical diagnostics.
Multi-pathogen combo test panels such as Flu A+B/RSV/ADV/hMPV/hRV/M.p/PIV and Dengue/Malaria combos
OEM/ODM services tailored to global market needs with CE-marked and internationally registered products.
GenSure operates through three core facilities in China:
Shanghai Headquarters with a 5,000 m² R&D center in Minhang District
Hebei Production Base with 18,000 m² GMP-compliant cleanroom facilities
Beijing Business Center focused on international sales and customer service
Driven by advanced automation, strict quality management, and market responsiveness, GenSure continues to empower global partners with flexible manufacturing, strong regulatory support, and scalable diagnostic solutions.
